These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 24329492)

  • 1. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition.
    Jing Y; Cui D; Guo W; Jiang J; Jiang B; Lu Y; Zhao W; Wang X; Jiang Q; Han B; Xia S
    Cancer Lett; 2014 Jun; 348(1-2):135-45. PubMed ID: 24662746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
    Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
    Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor is a potential therapeutic target for bladder cancer.
    Wu JT; Han BM; Yu SQ; Wang HP; Xia SJ
    Urology; 2010 Apr; 75(4):820-7. PubMed ID: 20083299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
    Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
    Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.
    Guo C; Zhu K; Sun W; Yang B; Gu W; Luo J; Peng B; Zheng J
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1226-31. PubMed ID: 24393848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
    Wu CL; Ho JY; Chou SC; Yu DS
    Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
    Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
    Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling.
    Tan M; Gong H; Zeng Y; Tao L; Wang J; Jiang J; Xu D; Bao E; Qiu J; Liu Z
    J Cell Biochem; 2014 Oct; 115(10):1762-7. PubMed ID: 24824041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.
    Li W; Kidiyoor A; Hu Y; Guo C; Liu M; Yao X; Zhang Y; Peng B; Zheng J
    Tumour Biol; 2015 Feb; 36(2):1155-62. PubMed ID: 25722217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.
    Hata S; Ise K; Azmahani A; Konosu-Fukaya S; McNamara KM; Fujishima F; Shimada K; Mitsuzuka K; Arai Y; Sasano H; Nakamura Y
    Life Sci; 2017 Dec; 190():15-20. PubMed ID: 28947209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
    Baumgart E; Cohen MS; Silva Neto B; Jacobs MA; Wotkowicz C; Rieger-Christ KM; Biolo A; Zeheb R; Loda M; Libertino JA; Summerhayes IC
    Clin Cancer Res; 2007 Mar; 13(6):1685-94. PubMed ID: 17363521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
    Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
    Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.